- Home
- » Tags
- » Dalbavancin
Top View
- Staphylococcus Aureus
- Gram-Positive Recs for Use for Newer MRSA Agents
- Antimicrobial Guide
- DALVANCE Label
- Handbook of Outpatient Parenteral Antimicrobial Therapy (OPAT)
- Xydalba, INN-Dalbavancin Hydrochloride
- Antibiotics Update
- Public Assessment Report
- Plasma Protein Binding of Colistin Measured by Ultracentrifugation and Equilibrium Dialysis in Teflon® Cells
- Antibiotic Considerations in the Treatment of Multidrug-Resistant (MDR) Pathogens: a Case-Based Review
- Dalbavancin for the Management of Gram-Positive Osteomyelitis: Effectiveness and Potential Utility☆
- Diabetic Foot Infections
- Antimicrobial Activity of Dalbavancin Tested Against Gram-Positive Clinical Isolates from Latin American Medical Centres A
- (ECOFF) for Dalbavancin and Enterococcus Faecium
- DALVANCE (Dalbavancin) for Injection, for Intravenous Use 6 to Less Than 18 Years 18 Mg/Kg (Maximum of 1500 Mg) Initial U.S
- 021883Orig1s000
- Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin Against Resistant Phenotypes of Staphylococcus Au
- STANDARD DALVANCE® (Dalbavancin) PLAN of TREATMENT of Palmetto Infusion Services
- Oritavancin Is Associated with Improved Economic Outcomes Vs. Dalbavancin in Patients with Acute Bacterial Skin and Skin Structu
- Dalbavancin/Oritavancin Infrequent Dosing: OPAT, ED Use, IE, Osteomyelitis, ABSSTI, Line Infection
- Inpatient Antibiotic Resistance
- Dalbavancin in Real Life: Economic Impact of Prescription Timing in French Hospitals
- Ceftaroline Fosamil: a Super-Cephalosporin?
- Glycopeptide Antibiotics: Back to the Future
- Activity and Spectrum Evaluation of Dalbavancin, a Novel "Glycopeptide" Class Antimicrobial R.N
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: a Randomized Clinical Trial of Efficacy and Safety
- Dalbavancin (Dalvance) February 2019 Non-Formulary (OP)
- What's Upwith Long- Acting Antibiotics
- Cellulitis and Erysipelas: Antimicrobial Prescribing Guideline Evidence Review
- Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients
- Staphylococcus Aureus
- Standard and High Dose Antibiotic Dosing Regimens
- Recently Approved Antibacterials for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Other Gram-Positive Pathogens: the Shock of the New Michael Z
- Staphylococcus Aureus Isolates
- Le Infezioni in Medicina
- Enterococcus Faecalis Endocarditis and Outpatient Treatment: a Systematic Review of Current Alternatives
- Nephropharmacology for the Clinician
- Role of Extended Dosing Interval Antimicrobials in OPAT
- The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance